Figure 3
From: Opiorphin as a biomarker of orofacial conditions: a meta-analysis
Forest plots indicating different concentration of opiorphins in saliva on orofacial pain conditions compared to controls. Graphs generated with Review Manager 5.3 (RevMan 5.3, The Nordic Cochrane Centre, Copenhagen, Denmark). (A) Chronic orofacial group (TMD, BMS and OPMD); (B) sustained pain group (SIP, SAP and POSC); (C) stimulated group (after CFB, and capsaicin). CI confidence interval, OPMDs oral potentially malignant disorders, POSC painful oral soft-tissue conditions, SAP symptomatic apical periodontitis, SIP symptomatic irreversible pulpitis, SD standard deviation, TTM treatment.
